Contact this trialFirst, we need to learn more about you.
Rifaximin for Breast Cancer-Related Gastrointestinal Side Effects
Recruiting3 awardsPhase 2
Jacksonville, Florida
This trial is studying if rifaximin can help reduce gastrointestinal side effects from pertuzumab-based therapy in patients with HER2 positive breast cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service